ArticleCancer research2019

MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53.

John Hines et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.